Gravar-mail: LGG-45. RESPONSE TO THE FIRST-LINE CHEMOTHERAPY IN PEDIATRIC LOW-GRADE GLIOMAS ACCORDING TO HISTOPATHOLOGY AND BRAF ALTERATIONS